2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

Speaking on The Cancer Letter Podcast, Taofeek Kunle Owonikoko recalled recent conversations with two junior faculty members at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.

April 18, 2025

Vol.51 No.15

By Paul Goldberg

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

Confidential Trump administration budget documents show that the upcoming FY26 Budget Request will radically cut about $50 billion out of the U.S. Department of Health and Human Services, reshuffling agency components, and slashing the number of NIH institutes and centers to just eight.

NCI summarizes changes to the CCSG NOFO

In an email sent to directors and deputy directors of NCI-designated cancer centers, Krzysztof Ptak, director of the NCI Office of Cancer Centers, provided a comparison between the newly issued Cancer Center Support Grant Notice of Funding Opportunity with the previous version of the document.

April 18, 2025

Vol.51 No.15

Clinical Roundup

Inherited cancer mutations may drive tumor growth, study shows

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A study led by researchers at Washington University School of Medicine in St. Louis takes a deep dive into inherited cancer mutations measured in a healthy blood sample and reports how those mutations might take a toll on the body’s cells starting at birth, perhaps predisposing a person to develop cancers at various stages of life.

April 18, 2025

Vol.51 No.15

Podcast

In The Headlines: Private funding can’t replace federal funding—but it can help

In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.

April 09, 2025

Vol.51 No.13

Conversation with The Cancer Letter

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.

April 04, 2025

Vol.51 No.13

By Paul Goldberg

2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

YOU MAY BE INTERESTED IN

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

NCI summarizes changes to the CCSG NOFO

Inherited cancer mutations may drive tumor growth, study shows

In The Headlines: Private funding can’t replace federal funding—but it can help

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Renew today!

Subscriber content

Never miss an issue!

Login

2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

YOU MAY BE INTERESTED IN

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty“We are resolute. We are committed to continuing to move the work forward.”

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eightNCI to remain intact, but its finances are uncertain; FDA is spared big cuts

NCI summarizes changes to the CCSG NOFO

Inherited cancer mutations may drive tumor growth, study shows

In The Headlines: Private funding can’t replace federal funding—but it can help

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

Never miss an issue!

Login

The Directors: Louis Weiner and Taofeek Owonikoko on keeping up morale amid uncertainty
“We are resolute. We are committed to continuing to move the work forward.”

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts